Habig Scott Michael
Chief Commercial Officer
1 company
Insider Signal Score
46
AverageTrades Analyzed
4
12M Win Rate
25.0%
Avg 3M Return
+12.9%
Avg 12M Return
-34.6%
Habig Scott Michael is a Chief Commercial Officer at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $7.5M based on current market prices.
Holdings by Company
AUPHAug 6, 2024
Current Shares456.3K
Value$7.51M
Net Activity-46,893
Bought: 5.0KSold: 51.9K
Transaction History
Showing 4 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Chief Commercial Officer | Sell | 18,249 | $5.31 | $96,902.19 | -3.8% | +28.3% | +106.6% | |
| Mar 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Chief Commercial Officer | Sell | 17,777 | $5.60 | $99,551.20 | -3.6% | -4.5% | +48.4% | |
| Feb 20, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Chief Commercial Officer | Sell | 15,867 | $5.48 | $86,951.16 | -3.1% | +3.4% | +40.8% | |
| Nov 9, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Chief Commercial Officer | Buy | 5,000 | $5.02 | $25,075.00 | New | +78.7% | +50.7% |